Anti-arthritic and anti-inflammatory activity of combined pioglitazone and prednisolone on adjuvant-induced arthritis

European Journal of Pharmacology

Volumn 718, Issue 1-3, 2013, Pages 57-62

  Suke, Sanvidhan G ^a   Negi, Harsh ^b,c   Mediratta, P K ^c   Banerjee, B D ^c   Sharma, K K ^c  

^a PRIYADARSHINI INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

^b R and D Division   (India)

^c UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Arthritis; Freund's complete adjuvant; Inflammation; Pioglitazone; Prednisolone

Indexed keywords

ACETYLSALICYLIC ACID; INTERLEUKIN 6; PIOGLITAZONE; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ANTIARTHRITIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG RESPONSE; FEMALE; INFLAMMATION; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; WEIGHT REDUCTION;

ARTHRITIS; FREUND'S COMPLETE ADJUVANT; INFLAMMATION; PIOGLITAZONE; PREDNISOLONE;

ANIMALS; ANKLE; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; BODY WEIGHT; DISEASE PROGRESSION; DRUG INTERACTIONS; FEMALE; INFLAMMATION; INTERLEUKIN-6; JOINTS; MALE; PREDNISOLONE; RATS; RATS, WISTAR; THIAZOLIDINEDIONES; TIBIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887029875     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.09.019     Document Type: Article

References (37)

1. J. Adriaansen, M.J. Vervoordeldonk, and P.P. Tak Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes Rheumatology 45 2006 656 668 (Pubitemid 43985333)
2. Y. Avnir, R. Ulmansky, V. Wasserman, S. Even-Chen, M. Broyer, Y. Barenholz, and Y. Naparstek Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis Arthritis & Rheumatism 58 2008 119 129
3. L. Azoulay, H. Yin, K.B. Filion, J. Assayag, A. Majdan, M.N. Pollak, and S. Suissa The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study British Medical Journal 344 2012 e3645
4. 10 therapy in adjuvant-induced arthritis evaluated using parameters of inflammation and oxidative stress Acta Biochimica Polonica 57 2010 347 354
5. S. Bernatsky, M. Hudson, and S. Suissa Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis Rheumatology 46 2007 1157 1160 (Pubitemid 47050621)
6. A. Biswas, S.I. Rabbani, and K. Devi Influence of pioglitazone on experimental heart failure and hyperlipidemia in rats Indian Journal of Pharmacology 44 2012 333 339
7. I.K. Campbell, L.J. Roberts, and I.P. Wicks Molecular targets in immune-mediated diseases: the case of tumour necrosis factor and rheumatoid arthritis Immunology & Cell Biology 81 2003 354 366 (Pubitemid 37255409)
8. E.H. Choy, and G.S. Panayi Cytokine pathways and joint inflammation in rheumatoid arthritis The New England Journal of Medicine 344 2001 907 916 (Pubitemid 32224400)
9. F.M. Cicuttini, K.A. Byron, D. Maher, A.M. Wootton, K.D. Muirden, and J.A. Hamilton Serum IL-4, IL-10 and IL-6 levels in inflammatory arthritis Rheumatology International 14 1995 201 206
10. M.G. Coelho, P.A. Reis, V.B. Gava, P.R. Marques, C.R. Gayer, G.A. Laranja, I. Felzenswalb, and K.C. Sabino Anti-arthritic effect and subacute toxicological evaluation of Baccharis genistelloides aqueous extract Toxicology Letters 154 2004 69 80 (Pubitemid 39314590)
11. D. Czock, F. Keller, F.M. Rasche, and U. Häussler Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids Clinical Pharmacokinetics 44 2005 61 98 (Pubitemid 40096038)
12. A.A. van Everdingen, J.W. Jacobs, D.R. Siewertsz Van Reesema, and J.W. Bijlsma Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy disease-modifying properties and side effects: a randomized double-blind placebo-controlled clinical trial Annals of Internal Medicine 136 2002 1 12 (Pubitemid 34038692)
13. H. Fahmi, J.A. Di Battista, J.P. Pelletier, F. Mineau, P. Ranger, and J. Martel-Pelletier Peroxisome proliferator - activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes Arthritis & Rheumatism 44 2001 595 607 (Pubitemid 32234618)
14. M. Feldmann, F.M. Brennan, and R.N. Maini Role of cytokines in rheumatoid arthritis Annual Review of Immunology 14 1996 397 440 (Pubitemid 26130190)
15. K. Ishihara, and T. Hirano IL-6 in autoimmune disease and chronic inflammatory proliferative disease Cytokine & Growth Factor Reviews 13 2002 357 368
16. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86 (Pubitemid 28079219)
17. M. Koufany, D. Moulin, A. Bianchi, M. Muresan, S. Sebillaud, P. Netter, G. Weryha, and J.Y. Jouzeau Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis Arthritis Research & Therapy 10 2008 R6
18. J.E. Kunicka, M.A. Talle, G.H. Denhardt, M. Brown, L.A. Prince, and G. Goldstein Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone Cellular Immunology 149 1993 39 49 (Pubitemid 23196002)
19. S.L. Kunkel, H. Ogawa, P.B. Conran, P.A. Ward, and R.B. Zurier Suppression of acute and chronic inflammation by orally administered prostaglandins Arthritis & Rheumatism 24 1981 1151 1158 (Pubitemid 11057342)
20. T.M. Larsen, S. Toubro, and A. Astrup PPAR gamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? International Journal of Obesity and Related Metabolic Disorders 27 2003 147 161 (Pubitemid 36255796)
21. H.S. Lin, C.Y. Hu, H.Y. Chan, Y.Y. Liew, H.P. Huang, and Lepescheux Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents British Journal of Pharmacology 150 2007 862 872 (Pubitemid 46536628)
22. M.M. Maurice, W.L. van der Graaff, A. Leow, F.C. Breedveld, R.A. van Lier, and C.L. Verweij Treatment with monoclonal anti-tumor necrosis factor alpha antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis Arthritis & Rheumatism 42 1999 2166 2173 (Pubitemid 30263601)
23. P. Nandi, G.H. Kingsley, and D.L. Scott Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis Current Opinion in Rheumatology 20 2008 251 256 (Pubitemid 351483312)
24. Pearson, C.M., Wood, F.D., 1963. Studies of arthritis and other lesions induced in rats by the injection of mycobacterial adjuvant. VII Pathologic details of the arthritis and spondylitis, American Journal of Pathology 42, 73-95.
25. M. Pierer, and C. Baerwald Biological therapy for the treatment of rheumatic diseases Internist (Berlin) 49 2008 938 946
26. R. Refaat, M. Salama, E. Abdel Meguid, A. El Sarha, and M. Gowayed Evaluation of the effect of losartan and methotrexate combined therapy in adjuvant-induced arthritis in rats European Journal of Pharmacology 698 2013 421 428
27. I. Rioja, K.A. Bush, J.B. Buckton, M.C. Dickson, and P.F. Life Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment Clinical & Experimental Immunology 137 2004 65 73 (Pubitemid 38869779)
28. E.D. Rosen, and B.M. Spiegelman PPAR gamma: a nuclear regulator of metabolism differentiation and cell growth The Journal of Biological Chemistry 276 2001 37731 37734
29. K. Saito, and Y. Tanaka New biologic and non biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis Nihon Rinsho Meneki Gakkai Kaishi 32 2009 149 159
30. I.C. Scott, S. Steer, C.M. Lewis, and A.P. Cope Precipitating and perpetuating factors of rheumatoid arthritis immunopathology: linking the triad of genetic predisposition, environmental risk factors and autoimmunity to disease pathogenesis Best Practice & Research Clinical Rheumatology 25 2011 447 468
31. D. Shahin, E. Eltoraby, A. Mesbah, and M. Houssen Insulin resistance in early untreated rheumatoid arthritis patients Clinical Biochemistry 43 2010 661 665
32. D. Shahin, E.E. Toraby, H. Abdel-Malek, V. Boshra, A.Z. Elsamanoudy, and D. Shaheen Effect of peroxisome proliferator-activated receptor gamma agonist (pioglitazone) and methotrexate on disease activity in rheumatoid arthritis (experimental and clinical study) Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 4 2011 1 10
33. S. Singh, V. Nair, and Y.K. Gupta Antiarthritic activity of Majoon Suranjan (a polyherbal Unani formulation) in rat Indian Journal of Medical Research 134 2011 384 388
34. S.G. Suke, R.S. Ahmed, R. Pathak, A.K. Tripathi, and B.D. Banerjee Attenuation of phosphamidon-induced oxidative stress and immune dysfunction in rats treated with N-acetylcysteine Brazilian Journal of Medical and Biological Research 41 2008 765 768
35. S. Thornton, L.E. Duwel, G.P. Boivin, Y. Ma, and R. Hirsch Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression Arthritis & Rheumatism 42 1999 1109 1118 (Pubitemid 29268947)
36. M.C. Wasko, J. Kay, E.C. Hsia, and M.U. Rahman Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease Arthritis Care & Research (Hoboken) 63 2011 512 521
37. T. Yoshikawa, H. Tanaka, and M. Kondo The increase in lipid peroxidation in rat adjuvant arthritis and its inhibition by superoxide dismutase Biochemical Medicine 33 1985 320 326 (Pubitemid 15044086)